Disclosure: We may earn a commission if you sign up through some links on this site, at no extra cost to you. We do not accept payment for favorable reviews. Read our full affiliate disclosure.
Embody at a Glance
- What it is
- Names four compounding pharmacies, which almost nobody does — then advertises an introductory price roughly a quarter of the ongoing one
- Medication type
- Compounded only
- Medications offered
- Compounded semaglutide (injection)
- Compounded tirzepatide (injection)
- Pricing
- Advertised $69/mo semaglutide and $119/mo tirzepatide — third parties report $299 and $349 ongoing
- Insurance
- Cash-pay only. Compounded medication is never covered by insurance.
- Date reviewed
- August 7, 2026
How we scored it
Scores follow the published rubric in our provider comparison methodology.
Medical Disclaimer
We're not doctors, and this review is not medical advice. GLP-1 medications are prescription-only and require evaluation by a licensed healthcare provider. What works for one person may not work for another, and only a clinician who knows your history can determine whether a medication is appropriate for you. See our full medical disclaimer.
What Is Embody?
Embody is a cash-pay GLP-1 telehealth platform operated by Modern Metabolic Medicine, Inc. Prescribing runs through OpenLoop Health, an established multi-state network of US-licensed clinicians, and medication is made and shipped by separate compounding pharmacies. It serves every US state except Louisiana, with Nebraska limited to patients aged 19 and over.
One thing here is genuinely better than the competition. Embody names its compounding partners — RedRock Pharmacy, Health Warehouse, Precision Compounding Pharmacy and Triad Rx — with addresses and phone numbers in its site footer. Almost no compounded provider does this. If you are going to take a medication that has not been through FDA review, being able to look up who made it is worth something real.
The marketing is a different matter. The landing page advertises $69/month for semaglutide and $119/month for tirzepatide against a struck-through "Was $299", beside a countdown headed "Price increases in" that was reading 00:00:00:00 when we checked — a timer that has expired and never resets is a manufactured-urgency device, not information. Third-party checks of Embody's own checkout in July 2026 reported the ongoing rate at $299/month for semaglutide and $349/month for tirzepatide, which suggests the "Was $299" is not a former price at all but what you pay from month two onward.
How the Program Works
- Consultation process
- Online intake with a telemedicine visit and clinician review, both included in the advertised price. No insurance is required or accepted.
- Eligibility
- Clinician-assessed at intake. Embody states it serves all US states except Louisiana, and that services in Nebraska are limited to patients 19 years of age or older. It does not publish a BMI threshold.
- Provider involvement
- Prescribing is handled by clinicians from OpenLoop Health, a Des Moines-based network of US-licensed doctors, rather than by employed Embody physicians. Ongoing support is provided by nursing staff. Some customer reviews report provider no-shows for scheduled appointments.
- Lab requirements
- Not published as a universal requirement.
- Pharmacy fulfillment
- Named, which is the standout feature. Embody lists RedRock Pharmacy, Health Warehouse, Precision Compounding Pharmacy and Triad Rx as its partner pharmacies, with contact details, and describes them as US-based 503A compounding pharmacies.
- Shipping frequency
- Monthly, with free shipping advertised as arriving in one to two days.
- Support services
- Telemedicine visits, prescription, supplies, shipping and ongoing nursing support, all included in the medication price.
Embody Pricing
- Membership fee
- None. Embody states repeatedly that there is no monthly membership and no hidden fees, and the advertised price covers the prescription, telemedicine visit, medication, supplies and shipping.
- Medication fee
- The landing page advertises compounded semaglutide at $69/month and compounded tirzepatide at $119/month, against a struck-through "Was $299". Independent checks of Embody's checkout in July 2026 reported ongoing pricing of $299/month for semaglutide and $349/month for tirzepatide, and separately reported new-customer rates of $79 and $129, so the introductory figure itself moves.
- Cancellation policy
- Embody advertises no long-term commitment and the ability to cancel at any time. Given the reported jump from the introductory rate, identify your renewal date and the price it renews at before the first month ends.
- Refund policy
- Embody states you receive a full refund if your prescription is not approved. It has also advertised a six-month money-back guarantee for members who follow the programme without meaningful progress — get the conditions of that in writing before relying on it, since it is not set out on the landing page.
- Insurance
- Cash-pay only. Compounded medication is never covered by insurance.
- HSA / FSA
- Not published. Prescription telehealth is commonly HSA/FSA-eligible; confirm with your administrator.
Pricing details worth knowing
- Treat the advertised price as a first-month rate, not a monthly rate. The single most common complaint against Embody is the gap between the entry price and what is charged afterwards.
- The "Was $299" strike-through appears to describe the ongoing price rather than a discontinued one, which inverts what a struck-through price normally communicates.
- The countdown timer headed "Price increases in" read 00:00:00:00 when we checked. An expired timer that never resets is a manufactured-urgency device.
- Pricing is reported to stay flat as your dose increases, which is a genuine advantage and something reviewers praise.
- Charges are reported to appear on statements as "CareValidate Inc." or carevalidate.com rather than Embody, which makes them easy to miss or mistake for fraud.
- Embody displays a 4.8/5 rating on its own site citing more than 125,000 customers. Its public Trustpilot profile carried roughly 3.6 out of 5 across about 3,220 reviews in July 2026.
Prices change. Every figure above was taken from Embody's published pages or the named sources at the bottom of this review, as of August 7, 2026. Telehealth pricing in this market changes frequently, and promotional rates expire. Confirm your actual cost at checkout before enrolling.
Pros and Cons
Pros
- Names all four of its compounding pharmacies with contact details — better disclosure than almost any competitor
- No membership fee; the price covers the visit, medication, supplies and shipping
- Flat pricing as your dose increases, which reviewers consistently praise
- Free shipping advertised at one to two days
- Prescribing through OpenLoop Health, a real and verifiable multi-state clinician network
- Available in 49 states, and a full refund if your prescription is not approved
Cons
- The advertised $69 and $119 are introductory — third parties report $299 and $349 ongoing
- An expired countdown timer reading 00:00:00:00 is used to manufacture urgency
- The site displays a 4.8/5 rating that its public Trustpilot profile does not support
- Card charges reportedly appear as "CareValidate Inc.", not Embody
- Complaints include provider no-shows for scheduled appointments
- No accessible BBB profile could be found for Embody or Modern Metabolic Medicine
- Compounded only, with no brand-name pathway
Who Embody May Be Best For
People who want to know which pharmacy compounds their medication — Embody actually tells you
Patients who expect to titrate to a high dose and want a price that does not climb with it
Anyone comfortable treating the first month as a trial and re-evaluating before the ongoing rate begins
Limitations
Find out what month two costs before you pay for month one. Ask support in writing, and keep the answer — the entry-to-ongoing price gap is the dominant complaint against this company.
Watch your statement for a charge from "CareValidate Inc." rather than Embody, so you do not mistake it for an unauthorised transaction or miss it entirely.
The six-month money-back guarantee is advertised off-site rather than in the terms we could read. Get its conditions confirmed before relying on it.
Not available in Louisiana, and restricted to those 19 and over in Nebraska.
About Compounded GLP-1s
The FDA declared the tirzepatide shortage resolved in December 2024 and the semaglutide shortage resolved in February 2025, which ended the window for compounding pharmacies to make large volumes of copies of those drugs (503A pharmacies had until April 22, 2025; 503B outsourcing facilities until May 22, 2025). Many telehealth companies continue to offer compounded GLP-1s prescribed for an individual patient — often as a personalized dose, a microdose, or a formulation combined with a vitamin such as B12 or B6. That practice sits in a contested legal area, and the FDA has continued to act. In a Federal Register notice published on May 1, 2026, the FDA proposed not to include semaglutide, tirzepatide or liraglutide on the 503B bulks list, saying it had not identified sufficient evidence of a clinical need for outsourcing facilities to compound them from bulk substances; the comment period was extended to July 30, 2026. Separately, in February 2026 the FDA issued warning letters to 30 telehealth companies over false or misleading claims about compounded GLP-1s, and it has continued: a further round dated 8 June 2026 — 25 warning letters, posted publicly on 16 June 2026 — reached companies including Medica Weight Loss, FITISH and Roen Health (RoenRx), again over false or misleading claims about compounded semaglutide and tirzepatide that the FDA said made the products misbranded under sections 502(a) and 502(bb) of the FD&C Act. The claims cited included suggesting the products were FDA-approved, implying equivalence to Ozempic, Wegovy, Mounjaro or Zepbound, and asserting the "same active ingredient" or "same results" as the approved drugs. Compounded medications are not FDA-approved, which means they have not gone through the same review as the brand-name products.
None of that is specific to Embody — it applies to every provider offering compounded medication. We cover the trade-offs in detail in our guide to brand-name versus compounded GLP-1s.
Alternatives to Embody
Ondra Health
Also names its compounding pharmacies, and publishes $96/mo without an introductory-rate structure
Read review →Trimi
Names its pharmacy and publishes $99/mo annually with the cheapest tirzepatide we found
Read review →NovoCare Pharmacy
FDA-approved Wegovy at $149/mo, with no compounding questions and no promotional pricing
Read review →vs. CoreAge RX, our top-rated platform
Across the platforms we've reviewed, CoreAge RX remains our highest-rated option for cash-pay patients, with compounded semaglutide from $99/month and tirzepatide from $149/month including free two-day shipping. Whether it beats Embody for you depends on the things this review has covered — insurance, medication type, and how much support you actually want.
Frequently Asked Questions
How much does Embody actually cost after the first month?
This is the question to settle before you sign up. Embody advertises $69/month for compounded semaglutide and $119/month for tirzepatide, but independent checks of its own checkout in July 2026 reported ongoing pricing of $299/month and $349/month respectively — roughly four times the advertised figure. The site's own struck-through "Was $299" is consistent with $299 being the standing price rather than a former one. Ask support in writing what your month-two charge will be, and keep the reply.
Is Embody legitimate?
Yes, in the sense that matters most: it is a real telehealth platform operated by Modern Metabolic Medicine, Inc., prescriptions are written by licensed clinicians through OpenLoop Health, and medication is compounded by named, contactable US pharmacies. It is not a fake pharmacy. Our concerns are about marketing honesty rather than legitimacy — an expired urgency countdown, an introductory price presented as the price, and a self-displayed 4.8/5 rating that its public Trustpilot profile does not support.
Which pharmacies does Embody use?
Embody names four in its site footer with addresses and phone numbers: RedRock Pharmacy, Health Warehouse, Precision Compounding Pharmacy and Triad Rx, described as US-based 503A compounding pharmacies. This is genuinely unusual and counts strongly in its favour — most compounded providers will not tell you who makes your medication. Note that 503A pharmacies compound for individual patients on prescription, and that compounded medication is not FDA-approved regardless of who prepares it.
Why does my bank statement say CareValidate?
Charges from Embody are reported to appear as "CareValidate Inc." or carevalidate.com rather than under the Embody name. That is a billing descriptor rather than anything sinister, but it catches people out — it makes the charge easy to mistake for fraud, and easy to overlook when you are checking whether a cancellation took effect. Note the descriptor when you sign up.
Is Embody available in my state?
Embody states it serves every US state except Louisiana, with services in Nebraska limited to patients aged 19 and over. State rules for compounded medication change frequently, so confirm at sign-up rather than relying on any published list.
Is Embody's compounded semaglutide FDA-approved?
No. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, efficacy or quality, whoever prepares them. Embody's medication is compounded by 503A pharmacies, which prepare medication for individual patients on a prescription. Naming those pharmacies is better practice than most of the market, but it does not change the regulatory status of the product.
Who should not use Embody?
Anyone who cannot absorb the ongoing price if the introductory rate ends as reported, and anyone who wants an FDA-approved product rather than a compounded one. Separately, GLP-1 medications are not appropriate if you have a personal or family history of medullary thyroid carcinoma or MEN 2, if you are pregnant or trying to conceive, or if you have had pancreatitis. Common side effects include nausea, vomiting, diarrhoea and constipation, particularly during titration. A licensed clinician who knows your history should make that assessment.
The Verdict
Embody, run by Modern Metabolic Medicine, advertises compounded semaglutide at $69/month and tirzepatide at $119/month with no membership fee, free two-day shipping and flat pricing as your dose climbs. It also names its four compounding pharmacies, which is rarer than it should be. Against that sits a marketing pattern we would want any reader to see first: the advertised rate is introductory, third-party checks put the ongoing price at $299 and $349, and the site displays a 4.8/5 rating its public review profile does not support.
Opens Embody's official site · Verify current pricing there
Compare Every Provider Side by Side
See how Embody stacks up against every platform we've reviewed on price, medication type, and what's actually included.
How We Researched This Review
We compiled this review on August 7, 2026 from Embody's own published pages plus independent reporting. We have not signed up for this service ourselves, and we say so rather than implying firsthand testing. Where Embody does not publish a detail — refund terms, lab requirements, pharmacy partners — we've said that plainly instead of guessing.
Sources
- joinem.co landing page — advertised $69/mo semaglutide and $119/mo tirzepatide, "Was $299", the "Price increases in 00:00:00:00" countdown, no membership fee, free 1–2 day shipping, refund if the prescription is not approved (checked August 7, 2026)
- joinem.co — coverage of all US states except Louisiana, Nebraska limited to 19+, OpenLoop Health named as the prescribing network, and the four named partner pharmacies (RedRock Pharmacy, Health Warehouse, Precision Compounding Pharmacy, Triad Rx) listed with contact details
- Third-party verification of Embody's checkout in July 2026 reporting ongoing pricing of $299/mo semaglutide and $349/mo tirzepatide, and new-customer rates of $79 and $129
- Trustpilot — approximately 3.6 out of 5 across about 3,220 reviews as of July 2026, against the 4.8/5 figure Embody displays on its own site; no accessible BBB profile located for Embody or Modern Metabolic Medicine
- Third-party reporting that card charges appear as "CareValidate Inc." / carevalidate.com, and on the advertised six-month money-back guarantee
Affiliate Disclosure: This review may contain affiliate links. If you click a link and sign up, we may receive a commission at no additional cost to you. We do not accept payment for favorable coverage, and commission relationships do not affect our scores. Read our full affiliate disclosure policy.